OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies
Hang Liang, Min Cui, Jingyao Tu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
Hang Liang, Min Cui, Jingyao Tu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
Showing 6 citing articles:
Advances on immunotherapy for osteosarcoma
Shengnan Yu, Xudong Yao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 31
Shengnan Yu, Xudong Yao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 31
Progress in immune microenvironment, immunotherapy and prognostic biomarkers in pediatric osteosarcoma
Lin Zhang, Haoming Jiang, Hongzhi Ma
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Lin Zhang, Haoming Jiang, Hongzhi Ma
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
A 10-year bibliometric analysis in the field of osteosarcoma treatment from 2014 to 2023
Yiguo Shen, Xiao-Bo Shao, Jiansong Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Yiguo Shen, Xiao-Bo Shao, Jiansong Chen, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
NF-κB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance
Shaoyan Shi, Xuehai Ou, Chao Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Shaoyan Shi, Xuehai Ou, Chao Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Advancements in Osteosarcoma Therapy: Overcoming Chemotherapy Resistance and Exploring Novel Pharmacological Strategies
Mahmoud Zhra, Shahid Akhtar Akhund, Khalid S. Mohammad
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 520-520
Open Access
Mahmoud Zhra, Shahid Akhtar Akhund, Khalid S. Mohammad
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 520-520
Open Access
IL-13Rα2 Is Involved in Resistance to Doxorubicin and Survival of Osteosarcoma Patients
Maryam Karamikheirabad, Junyue Zhang, Ae-Ri Ahn, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1526-1526
Open Access
Maryam Karamikheirabad, Junyue Zhang, Ae-Ri Ahn, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1526-1526
Open Access
